|
Session 131
Poster Abstracts
Treatment Outcomes in Scale-up Programs
Monday, 1-4 pm
Room: Hall B |
| 812 |
When to Start ART in Resource-limited Settings
Rochelle Walensky*1,2,3, L Wolf1, R Wood4, K Freedberg1,2,5,6, N Martinson7,8, D Paltiel9, X Anglaret10,11, M Fofana1, H Ribaudo5, and E Losina1,3,6
1Massachusetts Gen Hosp, Boston, US; 2Harvard Med Sch, Boston, MA, US; 3Brigham and Women`s Hosp, Boston, MA, US; 4Univ of Cape Town, South Africa; 5Harvard Sch of Publ Hlth, Boston, MA, US; 6Boston Univ Sch of Publ Hlth, MA, US; 7Perinatal HIV Res Unit, Johannesburg, South Africa; 8Johns Hopkins Univ Sch of Med, Baltimore, MD, US; 9Yale Univ Sch of Publ Hlth, New Haven, CT, US; 10Prgm PACCI, Abidjan Côte d`Ivoire; and 11Univ Victor Segalen, Bordeaux, France |
| 813 |
Evaluation of the Adult 2006 World Health Organization HIV/AIDS Clinical Staging in Predicting Initiation of ART in Uganda
Steven Baveewo*1, F Ssali2, C Karamagi1, and E Katabira1
1Makerere Univ Med Sch, Kampala, Uganda and 2Joint Clinical Res Ctr, Kampala, Uganda |
| 814 |
Normalization of CD4 Count in Thai Patients Started NNRTI-based Regimens at Low Nadir CD4 Count
Tanakorn Apornpong*1, N Phanuphak1, S Limpongsanurak2, W Luesomboon3, A Tangsathapornpong4, N Singhakovinta5, C Viravasiri6, P Toro7, E Abrams7, and P Phanuphak1
1Thai Red Cross AIDS Res Ctr, Bangkok; 2King Chulalongkorn Memorial Hosp, Bangkok, Thailand; 3Queen Sawangwattana Memorial Hosp, Chonburi, Thailand; 4Thammasat Univ Hosp, Bangkok, Thailand; 5Queen Sirikit Hosp, Chonburi, Thailand; 6Police Gen Hosp, Bangkok, Thailand; and 7Columbia Univ, New York, NY, US |
| 815 |
Evaluation of Outcomes in a Large HIV Comprehensive Scale-up Program: The Harvard PEPFAR Nigeria
Ernest Ekong*1, S Meloni2, D Onwujekwe3, C Okany4, I Adewole5, R Nkado6, W Gashau7, J Idoko8, R Murphy9, and P Kanki2
1APIN Plus/Harvard PEPFAR Nigeria, Lagos; 2Harvard-PEPFAR Prgm, Nigeria and Harvard Sch of Publ Hlth, Boston, MA, US; 3Nigerian Inst of Med Res, Lagos; 4Lagos Univ Teaching Hosp, Nigeria; 5Univ Coll Hosp, Ibadan, Nigeria; 668 Military Hosp, Lagos, Nigeria; 7Univ Maiduguri Teaching Hosp, Nigeria; 8Jos Univ Teaching Hosp, Nigeria; and 9Northwestern Univ, Chicago, IL, US |
| 816 |
Initial Treatment Outcomes from a Rural-based ART Scale-up Program in East Africa: The UARTO Cohort
Jeffrey Martin*1, N Emenyonu1, M Bwana2, I Andia2, J Bennett1, H Cao3, P Hunt1, R Harrigan4, S Deeks1, D Bangsberg1, and East Africa IeDEA Consortium
1Univ of California, San Francisco, US; 2Mbarara Univ of Sci and Tech, Uganda; 3California Dept of Hlth Svcs, Richmond, US; and 4BC Ctr for Excellence in HIV/AIDS, Vancouver, Canada |
| 817 |
Maximum Capacity of Restoration of CD4 Counts Is Lower in HIV-1-infected Patients from Sub-Saharan Africa during the First Months of cART: ATHENA Cohort
A Kesselring1, Luuk Gras*1, F Wit2,3, P Reiss2,3, and F de Wolf1
1HIV Monitoring Fndn, Amsterdam, The Netherlands; 2Academic Med Ctr, Univ of Amsterdam, The Netherlands; and 3Ctr for Poverty-Related Communicable Diseases, Amsterdam, The Netherlands |
| 818 |
Learning Curve: Increasing Benefit of HAART according to Year of Initiation in a Middle-income Country
Carlos Beltran*, D Gallardo, M Wolff, J Arancibia, C Gallo, M Ayala, I Becerra, S Karelovic, and Chilean AIDS Cohort
Chilean AIDS Cohort |
| 819 |
Mortality of HIV-1-infected Patients Starting ART in Sub-Saharan Africa: The IeDEA Prognostic Model
Margaret May*1, A Boulle2, E Messou3, H Tweya4, L Myer2, R Wood2, J Sterne1, M Schechter5, M Egger6, and ART-LINC and International epidemiological Databases to Evaluate AIDS (IeDEA) Southern and W. Africa
1Univ of Bristol, UK; 2Univ of Cape Town, South Africa; 3CeDReS, ACONDA, Abidjan, Côte d`Ivoire; 4Lighthouse Clin, Lilongwe, Malawi; 5Federal Univ of Rio de Janeiro, Brazil; and 6Univ of Berne, Switzerland |
| 820 |
Time Trends in Demographic and Clinical Characteristics of Patients Starting ART in Lower-income Countries: The ART-LINC Collaboration of IeDEA
O Keiser1, K Anastos2, E Balestre3, A Boulle4, P Braitstein5, M Brinkhof1, E Sprinz6, L Myer4, N Kumarasamy7, Francois Dabis*3, and the ART-LINC collaboration of IeDEA
1Univ of Bern, Switzerland; 2Lincoln Hosp, New York, NY, US; 3Univ Victor Segalen, Bordeaux, France; 4Univ of Cape Town, South Africa; 5Moi Univ, Eldoret, Kenya; 6Hosp de Clinicas de Porto Alegre, Brazil; and 7YRGCARE, Chennai, India |
| 821 |
Virologic Outcomes and ART Adherence in Adolescents Compared with Adults in Southern Africa
Jean Nachega*1, M Hislop2, D Dowdy1, M Cotton3, L Regensberg2, R Chaisson1, and G Maartens4
1Johns Hopkins Univ, Baltimore, MD, US; 2Aid for AIDS Disease Mgmt Prgm, Cape Town, South Africa; 3Univ of Stellenbosch, Tygerberg, South Africa; and 4Univ of Cape Town, South Africa |
| 822 |
2-Year Virologic Outcomes of an Alternative AIDS Care Model: Evaluation of a Peer Health Worker and Nurse-staffed Community-based Program in Uganda
S Alamo1, Larry Chang*2, S Guma1, J Christopher1, T Suntoke3, R Omastete1, J Montis1, T Quinn2,3, M Juncker1, and S Reynolds2,3
1Reach Out Mbuya Parish HIV/AIDS Initiative, Kampala, Uganda; 2Johns Hopkins Med Inst, Baltimore, MD, US; and 3NIAID, NIH, Bethesda, MD, US |
| 823 |
Immunologic Benefits of Complete vs Partial Virologic Suppression in Patients Initiating ART in Gugulethu, South Africa
Elena Losina*1,2,3, Y Chang2, R Kaplan4, E Campbell4, R Walensky1,2,5,6, K Freedberg2,3,5,6, and R Wood4
1Brigham and Women`s Hosp, Boston, MA, US; 2Massachusetts Gen Hosp, Boston, US; 3Boston Univ Sch of Publ Hlth, MA, US; 4Univ of Cape Town, South Africa; 5Harvard Med Sch, Boston, MA, US; and 6Harvard Sch of Publ Hlth, Boston, MA, US |
| 824 |
Predictors of Clinical and Immunological Outcomes among HIV-infected Subjects on ART in Tanzania
Guerino Chalamilla*1, M Mwanyika-Sando2, C Hawkins1, S Unni1, S Kaaya2, A Kibao3, D Mtasiwa3, and W Fawzi1
1Harvard Sch of Publ Hlth, Boston, MA, US; 2Muhimbili Univ of Hlth and Allied Sci, Dar es Salaam, Tanzania; and 3Dar es Salaam City Council, Tanzania |
| 825 |
Risk Factors for Discordant Responses to HAART at Themba Lethu Clinic, Johannesburg, South Africa
Daniel Westreich*1, B Malope2, P MacPhail2, S Nagar2, A Van Rie1, and I Sanne2
1Univ of North Carolina at Chapel Hill, Sch of Publ Hlth, US and 2Univ of the Witwatersrand, Johannesburg, South Africa |
| 826 |
Effect of Early Immunovirologic Discordant Responses on Mortality in Naïve HIV-1-infected Adults Initiating Treatment in Resource-constrained Countries
Suely Tuboi*1, A Pacheco2, P Braitstein3, M May4, R Stone1, E Sprinz5, D Nash6, R Wood7, L Harrison1, M Schechter8, and ART-LINC of IeDEA
1Univ of Pittsburgh, PA, US; 2Oswaldo Cruz Fndn, Rio de Janeiro, Brazil; 3Indiana Univ Sch of Med, Indianapolis, US and Moi Univ Sch of Med, Eldoret, Kenya; 4Univ of Bristol, UK; 5Federal Univ of Rio Grande do Sul, Porte Alegre, Brazil; 6Columbia Univ, New York, NY, US; 7Univ of Cape Town, South Africa; and 8Federal Univ of Rio de Janeiro, Brazil |
| 827 |
Determinants of Knowledge of Access to ART in Rural KwaZulu-Natal, South Africa
Till Barnighausen*1,2, F Tanser1, G Cooke1,3, and M L Newell1,4
1Africa Ctr for Hlth and Population Studies, Univ of KwaZulu Natal, Somkhele, South Africa; 2Harvard Sch of Publ Hlth, Boston, MA, US; 3Imperial Coll, London, UK; and 4Inst of Child Hlth, London, UK |
| 828 |
Novel Modular Education of Inpatients with AIDS in a Resource-poor National AIDS Treatment Centre: Impact of Learning Outcomes on Adherence to HAART and Cotrimoxazole Prophylaxis, Development of Opportunistic Infections, and Mortality
Olusegun Busari*, G Oligbu, O Busari, and HIV Study Group
Federal Med Ctr, Ido-Ekiti, Nigeria |
| 829 |
Changes in Depression and Daily Functioning with Initiation of ART in HIV-infected Adults in Rural Uganda
Naomi Bock*1, C W Lee1, S Bechange2, J Moore1, K Khana2, W Were2, R King2, J Mermin2, F Kaharuza2, and R Bunnell2
1CDC, Atlanta, GA, US and 2CDC Uganda, Entebbe |
| 830 |
Rapid Implementation of More Efficacious ART Regimens for the Prevention of Mother-to-Child Transmission of HIV in Rwanda
Landry Tsague*1, G Tene1, C Adje-Toure1, S Koblavi1, V Mugisha1, J Rubin1, G Vandebriel1, R Sahabo1, F Tsiouris2, and E Abrams2
1Columbia Univ, Intl Ctr for AIDS Care and Treatment Prgms, Kigali, Rwanda and 2Columbia Univ Mailman Sch of Publ Hlth, New York, NY, US |
|
